---
document_datetime: 2025-12-02 06:36:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/biograstim.html
document_name: biograstim.html
version: success
processing_time: 0.106718
conversion_datetime: 2025-12-29 19:20:27.956002
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Biograstim

[RSS](/en/individual-human-medicine.xml/66793)

##### Withdrawn

This medicine's authorisation has been withdrawn

filgrastim Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 September 2015, the European Commission withdrew the marketing authorisation for Biograstim (filgrastim) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, AbZ Pharma GmbH, who notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Biograstim was granted marketing authorisation in the EU on 15 September 2008 for treatment of neutropenia. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity. Biograstim is a biosimilar medicine of the reference medicinal product Neupogen and Biograstim was authorised in the EU for reducing the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for reducing the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation who were considered to be at increased risk of prolonged severe neutropenia.

Additional indications of Biograstim include mobilising peripheral blood progenitor cells (PBPC) in graft donors, increasing neutrophil counts and reducing the incidence and duration of infection-related events in patients with severe congenital, cyclic, or idiopathic neutropenia, and treating persistent neutropenia in patients with advanced HIV infection.

The European public assessment report (EPAR) for Biograstim is updated to indicate that the marketing authorisation is no longer valid.

Biograstim : EPAR - Summary for the public

English (EN) (490.35 KB - PDF)

**First published:** 29/09/2008

**Last updated:** 19/01/2017

[View](/en/documents/overview/biograstim-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-726)

български (BG) (644.88 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/bg/documents/overview/biograstim-epar-summary-public_bg.pdf)

español (ES) (478.69 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/es/documents/overview/biograstim-epar-summary-public_es.pdf)

čeština (CS) (620.41 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/cs/documents/overview/biograstim-epar-summary-public_cs.pdf)

dansk (DA) (478.5 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/da/documents/overview/biograstim-epar-summary-public_da.pdf)

Deutsch (DE) (493.12 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/de/documents/overview/biograstim-epar-summary-public_de.pdf)

eesti keel (ET) (477.74 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/et/documents/overview/biograstim-epar-summary-public_et.pdf)

ελληνικά (EL) (662.94 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/el/documents/overview/biograstim-epar-summary-public_el.pdf)

français (FR) (478.96 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/fr/documents/overview/biograstim-epar-summary-public_fr.pdf)

italiano (IT) (478.39 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/it/documents/overview/biograstim-epar-summary-public_it.pdf)

latviešu valoda (LV) (621.04 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/lv/documents/overview/biograstim-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (591.42 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/lt/documents/overview/biograstim-epar-summary-public_lt.pdf)

magyar (HU) (611.88 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/hu/documents/overview/biograstim-epar-summary-public_hu.pdf)

Malti (MT) (622.5 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/mt/documents/overview/biograstim-epar-summary-public_mt.pdf)

Nederlands (NL) (478.55 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/nl/documents/overview/biograstim-epar-summary-public_nl.pdf)

polski (PL) (625.6 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/pl/documents/overview/biograstim-epar-summary-public_pl.pdf)

português (PT) (478.73 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/pt/documents/overview/biograstim-epar-summary-public_pt.pdf)

română (RO) (585.72 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/ro/documents/overview/biograstim-epar-summary-public_ro.pdf)

slovenčina (SK) (617.04 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/sk/documents/overview/biograstim-epar-summary-public_sk.pdf)

slovenščina (SL) (608.2 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/sl/documents/overview/biograstim-epar-summary-public_sl.pdf)

Suomi (FI) (478.13 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/fi/documents/overview/biograstim-epar-summary-public_fi.pdf)

svenska (SV) (478.72 KB - PDF)

**First published:**

29/09/2008

**Last updated:**

19/01/2017

[View](/sv/documents/overview/biograstim-epar-summary-public_sv.pdf)

## Product information

Biograstim : EPAR - Product Information

English (EN) (1.62 MB - PDF)

**First published:** 10/11/2009

**Last updated:** 19/01/2017

[View](/en/documents/product-information/biograstim-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-578)

български (BG) (2.55 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/bg/documents/product-information/biograstim-epar-product-information_bg.pdf)

español (ES) (930.83 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/es/documents/product-information/biograstim-epar-product-information_es.pdf)

čeština (CS) (1.9 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/cs/documents/product-information/biograstim-epar-product-information_cs.pdf)

dansk (DA) (883.39 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/da/documents/product-information/biograstim-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/de/documents/product-information/biograstim-epar-product-information_de.pdf)

eesti keel (ET) (876.7 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/et/documents/product-information/biograstim-epar-product-information_et.pdf)

ελληνικά (EL) (3.06 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/el/documents/product-information/biograstim-epar-product-information_el.pdf)

français (FR) (926.38 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/fr/documents/product-information/biograstim-epar-product-information_fr.pdf)

hrvatski (HR) (945.83 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/hr/documents/product-information/biograstim-epar-product-information_hr.pdf)

íslenska (IS) (1.1 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/is/documents/product-information/biograstim-epar-product-information_is.pdf)

italiano (IT) (954.08 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/it/documents/product-information/biograstim-epar-product-information_it.pdf)

latviešu valoda (LV) (1.98 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/lv/documents/product-information/biograstim-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1009.87 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/lt/documents/product-information/biograstim-epar-product-information_lt.pdf)

magyar (HU) (1.87 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/hu/documents/product-information/biograstim-epar-product-information_hu.pdf)

Malti (MT) (1.91 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/mt/documents/product-information/biograstim-epar-product-information_mt.pdf)

Nederlands (NL) (924.38 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/nl/documents/product-information/biograstim-epar-product-information_nl.pdf)

norsk (NO) (1.06 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/no/documents/product-information/biograstim-epar-product-information_no.pdf)

polski (PL) (1.99 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/pl/documents/product-information/biograstim-epar-product-information_pl.pdf)

português (PT) (892.48 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/pt/documents/product-information/biograstim-epar-product-information_pt.pdf)

română (RO) (1010.64 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/ro/documents/product-information/biograstim-epar-product-information_ro.pdf)

slovenčina (SK) (1.86 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sk/documents/product-information/biograstim-epar-product-information_sk.pdf)

slovenščina (SL) (1.8 MB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sl/documents/product-information/biograstim-epar-product-information_sl.pdf)

Suomi (FI) (912.09 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/fi/documents/product-information/biograstim-epar-product-information_fi.pdf)

svenska (SV) (886.58 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sv/documents/product-information/biograstim-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0029 23/09/2015

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Biograstim : EPAR - All Authorised presentations

English (EN) (481.73 KB - PDF)

**First published:** 10/11/2009

**Last updated:** 19/01/2017

[View](/en/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-756)

български (BG) (575.54 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/bg/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_bg.pdf)

español (ES) (467.5 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/es/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_es.pdf)

čeština (CS) (584.07 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/cs/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (467.19 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/da/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (478.83 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/de/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (466.75 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/et/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (608.41 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/el/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_el.pdf)

français (FR) (466.91 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/fr/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (468.35 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/it/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (568.92 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/lv/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (535.46 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/lt/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (566.61 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/hu/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (568.78 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/mt/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (471.13 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/nl/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_nl.pdf)

polski (PL) (551.71 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/pl/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_pl.pdf)

português (PT) (468.44 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/pt/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_pt.pdf)

română (RO) (533.54 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/ro/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (569.21 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sk/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (479.4 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sl/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (466.59 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/fi/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (466.49 KB - PDF)

**First published:**

10/11/2009

**Last updated:**

19/01/2017

[View](/sv/documents/all-authorised-presentations/biograstim-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Biograstim Active substance filgrastim International non-proprietary name (INN) or common name filgrastim Therapeutic area (MeSH)

- Hematopoietic Stem Cell Transplantation
- Cancer

Anatomical therapeutic chemical (ATC) code L03AA02

### Pharmacotherapeutic group

Colony stimulating factors

### Therapeutic indication

Biograstim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia. The safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.

Biograstim is indicated for the mobilisation of peripheral blood progenitor cells (PBPC).

In patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of 0.5 x 10 9 /l, and a history of severe or recurrent infections, long-term administration of Biograstim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.

Biograstim is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 10 9 /l) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.

## Authorisation details

EMA product number EMEA/H/C/000826

Biosimilar

This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the 'reference medicine'. For more information, see [Biosimilar medicines](/node/68323) .

Marketing authorisation holder

AbZ-Pharma GmbH

Graf -Arco-Strase 3

Marketing authorisation issued 15/09/2008 Withdrawal of marketing authorisation 23/09/2015 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Biograstim : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (618.81 KB - PDF)

**First published:** 10/11/2009

**Last updated:** 19/01/2017

[View](/en/documents/procedural-steps-after/biograstim-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Biograstim : EPAR - Public assessment report

English (EN) (1.84 MB - PDF)

**First published:** 29/09/2008

**Last updated:** 19/01/2017

[View](/en/documents/assessment-report/biograstim-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Biograstim

Reference Number: EMEA/CHMP/371648/2008

English (EN) (530.48 KB - PDF)

**First published:** 25/07/2008

**Last updated:** 19/01/2017

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-biograstim_en.pdf)

**This page was last updated on** 19/01/2017

## Share this page

[Back to top](#main-content)